![]() |
||||||
|
![]() | Fusion Gene Summary |
![]() | Fusion Gene ORF analysis |
![]() | Fusion Genomic Features |
![]() | Fusion Protein Features |
![]() | Fusion Gene Sequence |
![]() | Fusion Gene PPI analysis |
![]() | Related Drugs |
![]() | Related Diseases |
Fusion gene:IGF2R-PCDH17 (FusionGDB2 ID:HG3482TG27253) |
Fusion Gene Summary for IGF2R-PCDH17 |
![]() |
Fusion gene information | Fusion gene name: IGF2R-PCDH17 | Fusion gene ID: hg3482tg27253 | Hgene | Tgene | Gene symbol | IGF2R | PCDH17 | Gene ID | 3482 | 27253 |
Gene name | insulin like growth factor 2 receptor | protocadherin 17 | |
Synonyms | CD222|CI-M6PR|CIMPR|M6P-R|M6P/IGF2R|MPR 300|MPR1|MPR300|MPRI | PCDH68|PCH68 | |
Cytomap | ('IGF2R')('PCDH17') 6q25.3 | 13q21.1 | |
Type of gene | protein-coding | protein-coding | |
Description | cation-independent mannose-6-phosphate receptor300 kDa mannose 6-phosphate receptorCI Man-6-P receptorIGF-II receptorM6P/IGF2 receptorinsulin-like growth factor II receptor | protocadherin-17protocadherin 68 | |
Modification date | 20200315 | 20200313 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000356956, ENST00000475584, | ||
Fusion gene scores | * DoF score | 23 X 16 X 11=4048 | 4 X 6 X 2=48 |
# samples | 25 | 6 | |
** MAII score | log2(25/4048*10)=-4.01720929003222 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(6/48*10)=0.321928094887362 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: IGF2R [Title/Abstract] AND PCDH17 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | IGF2R(160390427)-PCDH17(58240601), # samples:1 IGF2R(160390427)-PCDH17(58240602), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | IGF2R-PCDH17 seems lost the major protein functional domain in Hgene partner, which is a tumor suppressor due to the frame-shifted ORF. IGF2R-PCDH17 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. IGF2R-PCDH17 seems lost the major protein functional domain in Tgene partner, which is a tumor suppressor due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | BRCA | TCGA-C8-A12L-01A | IGF2R | chr6 | 160390427 | + | PCDH17 | chr13 | 58240602 | + |
ChimerDB4 | BRCA | TCGA-C8-A12L | IGF2R | chr6 | 160390427 | + | PCDH17 | chr13 | 58240601 | + |
Top |
Fusion Gene ORF analysis for IGF2R-PCDH17 |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Frame-shift | ENST00000356956 | ENST00000377918 | IGF2R | chr6 | 160390427 | + | PCDH17 | chr13 | 58240602 | + |
Frame-shift | ENST00000356956 | ENST00000377918 | IGF2R | chr6 | 160390427 | + | PCDH17 | chr13 | 58240601 | + |
intron-3CDS | ENST00000475584 | ENST00000377918 | IGF2R | chr6 | 160390427 | + | PCDH17 | chr13 | 58240602 | + |
intron-3CDS | ENST00000475584 | ENST00000377918 | IGF2R | chr6 | 160390427 | + | PCDH17 | chr13 | 58240601 | + |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for IGF2R-PCDH17 |
![]() |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
IGF2R | chr6 | 160390427 | + | PCDH17 | chr13 | 58240601 | + | 3.65E-09 | 1 |
IGF2R | chr6 | 160390427 | + | PCDH17 | chr13 | 58240601 | + | 3.65E-09 | 1 |
IGF2R | chr6 | 160390427 | + | PCDH17 | chr13 | 58240601 | + | 3.65E-09 | 1 |
IGF2R | chr6 | 160390427 | + | PCDH17 | chr13 | 58240601 | + | 3.65E-09 | 1 |
![]() |
![]() |
Top |
Fusion Protein Features for IGF2R-PCDH17 |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:160390427/:58240601) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
. | . |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for IGF2R-PCDH17 |
![]() |
Top |
Fusion Gene PPI Analysis for IGF2R-PCDH17 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for IGF2R-PCDH17 |
![]() (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for IGF2R-PCDH17 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | IGF2R | C0024115 | Lung diseases | 2 | CTD_human |
Hgene | IGF2R | C0235833 | Congenital diaphragmatic hernia | 2 | CTD_human |
Hgene | IGF2R | C0265699 | Congenital hernia of foramen of Morgagni | 2 | CTD_human |
Hgene | IGF2R | C0265700 | Congenital hernia of foramen of Bochdalek | 2 | CTD_human |
Hgene | IGF2R | C0002395 | Alzheimer's Disease | 1 | CTD_human |
Hgene | IGF2R | C0011265 | Presenile dementia | 1 | CTD_human |
Hgene | IGF2R | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
Hgene | IGF2R | C0030567 | Parkinson Disease | 1 | CTD_human |
Hgene | IGF2R | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
Hgene | IGF2R | C0242973 | Ventricular Dysfunction | 1 | CTD_human |
Hgene | IGF2R | C0276496 | Familial Alzheimer Disease (FAD) | 1 | CTD_human |
Hgene | IGF2R | C0376358 | Malignant neoplasm of prostate | 1 | CTD_human |
Hgene | IGF2R | C0494463 | Alzheimer Disease, Late Onset | 1 | CTD_human |
Hgene | IGF2R | C0546126 | Acute Confusional Senile Dementia | 1 | CTD_human |
Hgene | IGF2R | C0553980 | Endomyocardial Fibrosis | 1 | CTD_human |
Hgene | IGF2R | C0750900 | Alzheimer's Disease, Focal Onset | 1 | CTD_human |
Hgene | IGF2R | C0750901 | Alzheimer Disease, Early Onset | 1 | CTD_human |
Hgene | IGF2R | C0752347 | Lewy Body Disease | 1 | CTD_human |
Hgene | IGF2R | C2239176 | Liver carcinoma | 1 | CGI;CTD_human |
Tgene | C0036341 | Schizophrenia | 1 | PSYGENET |